OMKAR PHARMACHEM LIMITED · (CERC) advised IEX to resume trading in only Non-Solar REC Market....

3
Date: 07/09/2017 OMKAR PHARMACHEM LIMITED CIN L2423lGJ1995PLC025276 501, Mahakant Building, Opp, V.S. Hospital, Ashram road, Ellisbridge, Ahmedabad-380 006. Website www.omkarpharmachem.co.in Email [email protected] To, Bombay Stock Exchange Limited, Phiroz Jeejeebhoy Towers, Dalal Street, Mumbai-400001 Sub; - Notice of Newspaper Advertisement for Convening Board Meeting for the Quarter ending on 30 th June. 2017. Company Scrip Code; 532167 Dear Sir, Please find enclosed herewith copy of newspapers, one in vernacular language and one in English, in which advertisement for convening the Board Meeting, to consider, approve and take on record the Unaudited financial results for the quarter ended on 30 th June, 2017, pursuant to regulation 33 of the of the SEBI (Listing Obligation And Disclosure Requirement) Regulation 2015 has been given. Thanking you, Yours faithfully, For Omkar Pharmachem Limited (Anurag Sharma) Managing Director DIN02289261 Add: A-727, Sarita Vihar, New Delhi, 110076 Encl:a/a

Transcript of OMKAR PHARMACHEM LIMITED · (CERC) advised IEX to resume trading in only Non-Solar REC Market....

Page 1: OMKAR PHARMACHEM LIMITED · (CERC) advised IEX to resume trading in only Non-Solar REC Market. Pursuant to regulation 29, 33 and 47 of the SEBI (Listing Obligation and Disclosure

Date: 07/09/2017

OMKAR PHARMACHEM LIMITEDCIN L2423lGJ1995PLC025276

501, Mahakant Building,Opp, V.S. Hospital,

Ashram road, Ellisbridge,Ahmedabad-380 006.

Website www.omkarpharmachem.co.inEmail [email protected]

To,Bombay Stock Exchange Limited,Phiroz Jeejeebhoy Towers,Dalal Street,Mumbai-400001

Sub; - Notice of Newspaper Advertisement for Convening Board Meetingfor the Quarter ending on 30th June. 2017. Company Scrip Code; 532167

Dear Sir,

Please find enclosed herewith copy of newspapers, one in vernacularlanguage and one in English, in which advertisement for convening theBoard Meeting, to consider, approve and take on record the Unauditedfinancial results for the quarter ended on 30th June, 2017, pursuant toregulation 33 of the of the SEBI (Listing Obligation And DisclosureRequirement) Regulation 2015 has been given.

Thanking you,

Yours faithfully,For Omkar Pharmachem Limited

(Anurag Sharma)Managing DirectorDIN 02289261Add: A-727, Sarita Vihar, New Delhi, 110076

Encl: a/a

Page 2: OMKAR PHARMACHEM LIMITED · (CERC) advised IEX to resume trading in only Non-Solar REC Market. Pursuant to regulation 29, 33 and 47 of the SEBI (Listing Obligation and Disclosure

AHMEDABAD | FRIDAY, 8 SEPTEMBER 2017 5. <

REC Market: Price & Volume-30 August 2017Volume (REC) Price (Rs/REC)

Non-Solar 81,545 1,500

Electricity Market: Price & Volume-August 2017

DAY-AHEAD MARKETTotal

Volume (MU)*3,982 Average Daily

Volume (MU)128

TERM-AHEAD MARKETContracts Weekly Intraday Day-ahead

ContingencyDaily

Total Volume (MWh)* – 26,549 19,196 70,568

Max Price (Rs/kWh) – 8.00 7.50 3.50

Min Price (Rs/kWh) – 1.00 1.90 3.50

For any further information, please contact:Indian Energy Exchange Limited (CIN: U74999DL2007PLC277039)

Tel: +91-11-4300 4022/33 | Email: [email protected] | www.iexindia.com

Area Prices (Rs/kWh)

Area Average Min Max

East, North East, West 3.07 0.40 8.00

North 3.08 0.40 8.00

South 3.27 0.50 8.00

* MU = Million Units

Discoms | Industries Buy 24x7 power

After two month pause in REC trading (May and June’17), on 20 July 2017, the Honorable Central Electricity Regulatory Commission (CERC) advised IEX to resume trading in only Non-Solar REC Market.

Pursuant to regulation 29, 33 and 47 of the SEBI (Listing Obligation and Disclosure Requirement) Regulation 2015, notice is hereby given that a meeting of the Board of Directors will be held on Thursday,14th september, 2017 at 1.00 p.m. at the registered office of the company inter alia to consider, approve and take on record Unaudited financial results for the quarter ended on 30th June, 2017.The said details is also available on the website of the company www.omkarpharmachem.co.in and at the stock exchange sitehttp://www.bseindia.com/stock-share-price/omkarpharmachemltd/omkarph/532167/

OMKAR PHARMACHEM LIMITED501, Mahakant Building, Opp. V.S. Hospital, Ashram Road, Ellisbridge,

Ahmedabad-380 006. E-mail : [email protected] CIN: L24231GJ1995PLC025276 Website : www.omkarpharmachem.co.in

For, Omkar Pharmachem Ltd.,sd/-

Mr. Anurag Sharma (M.D.) Din 02289261

A-727, Sarita Vihar, New Delhi, 110076

Place : AhmedabadDate : 06/09/2017

NOTICE

Page 3: OMKAR PHARMACHEM LIMITED · (CERC) advised IEX to resume trading in only Non-Solar REC Market. Pursuant to regulation 29, 33 and 47 of the SEBI (Listing Obligation and Disclosure